-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 BGR197PR1lioD+1fnzNS4qdh4umM5SXrB53p0VSQj2SmMfMcVyStgKZHMoEKw1hz
 PNaP7A/1Xr1F1WjG1Xr0XQ==

<SEC-DOCUMENT>0001179022-03-000239.txt : 20031010
<SEC-HEADER>0001179022-03-000239.hdr.sgml : 20031010
<ACCEPTANCE-DATETIME>20031010170123
ACCESSION NUMBER:		0001179022-03-000239
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20031008
FILED AS OF DATE:		20031010

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			TRANSTECH PHARMA INC
		CENTRAL INDEX KEY:			0001087201

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23047
		FILM NUMBER:		03937496

	BUSINESS ADDRESS:	
		STREET 1:		7393 WOLF SPRING TRACE
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40241

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIGA TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001010086
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133864870
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		420 LEXINGTON AVE
		STREET 2:		SUITE 601
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170
		BUSINESS PHONE:		2126729100

	MAIL ADDRESS:	
		STREET 1:		420 LEXINGTON AVE
		STREET 2:		SUITE 601
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SIGA PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19961108
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>
    <schemaVersion>X0201</schemaVersion>

    <documentType>3</documentType><periodOfReport>2003-10-08</periodOfReport>
    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001010086</issuerCik>
        <issuerName>SIGA TECHNOLOGIES INC</issuerName>
        <issuerTradingSymbol>SIGA</issuerTradingSymbol></issuer><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001087201</rptOwnerCik>
            <rptOwnerName>TRANSTECH PHARMA INC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>4170 MENDENHALL OAKS PARKWAY</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE 110</rptOwnerStreet2>
            <rptOwnerCity>HIGH POINT</rptOwnerCity>
            <rptOwnerState>NC</rptOwnerState>
            <rptOwnerZipCode>27265</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
<isDirector>0</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>1</isTenPercentOwner><isOther>0</isOther></reportingOwnerRelationship></reportingOwner><derivativeTable><derivativeHolding><securityTitle><value>Option (right to buy)</value></securityTitle><conversionOrExercisePrice><value>1.44</value></conversionOrExercisePrice><exerciseDate><value>2003-08-13</value></exerciseDate><expirationDate><value>2003-10-13</value></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common Stock, par value $0.0001 per share (&quot;Common Stock&quot;)</value></underlyingSecurityTitle><underlyingSecurityShares><value>3472222</value><footnoteId id="F1"/></underlyingSecurityShares></underlyingSecurity><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership><natureOfOwnership><value/></natureOfOwnership></ownershipNature></derivativeHolding><derivativeHolding><securityTitle><value>Option (right to buy)</value></securityTitle><conversionOrExercisePrice><footnoteId id="F1"/>
</conversionOrExercisePrice><exerciseDate><value>2003-08-13</value></exerciseDate><expirationDate><value>2003-10-13</value></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Warrant</value></underlyingSecurityTitle><underlyingSecurityShares><value>1736111</value><footnoteId id="F1"/></underlyingSecurityShares></underlyingSecurity><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership><natureOfOwnership><value/></natureOfOwnership></ownershipNature></derivativeHolding></derivativeTable><footnotes><footnote id="F1">On August 13, 2003, MacAndrews &amp; Forbes Holdings Inc. (&quot;Holdings&quot;), and SIGA Technologies, Inc. (the &quot;Company&quot;) entered into a Securities Purchase Agreement (the &quot;Purchase Agreement&quot;).  Pursuant to the Purchase Agreement, Holdings acquired an option (the &quot;SIGA Option&quot;), exercisable from time to time, to purchase (a) up to 6,146,875 shares of Common Stock (&quot;Tranche B Shares&quot;) at a per share purcha
se price of $1.44 and (b) a warrant to purchase a number of shares of Common Stock equal to 50% of the number of Tranche B Shares, exercisable for $2.00 per share, for no additional consideration.  On October 8, 2003, in accordance with the Purchase Agreement, Holdings assigned a portion of the SIGA Option to the filing person, for no consideration.  The filing person and Holdings are each affiliated with Ronald Perelman.  Mr. Perelman disclaims benefical ownership of all securities reported on this Form 3, except to the extent of his pecuniary interest therein.</footnote></footnotes><remarks/><ownerSignature><signatureName>Conrad D. Brooks, by power of attorney</signatureName><signatureDate>2003-10-10</signatureDate></ownerSignature></ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>3
<FILENAME>transtechpoa.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
<html>

<head>
<meta name="GENERATOR" content="Microsoft FrontPage 5.0">
<meta name="ProgId" content="FrontPage.Editor.Document">
<title>POWER OF ATTORNEY</title>
</head>

<body>

<b>
<p ALIGN="CENTER">POWER OF ATTORNEY</p>
</b>
<p style="text-indent: 25">KNOW ALL MEN BY THESE PRESENTS, that the undersigned,
TransTech Pharma, Inc., a Delaware corporation, constitutes and appoints Conrad
Brooks and David Brown, and each of them, its true and lawful attorneys-in-fact
and agents, with full power of substitution, for it and in its name, place and
stead, in any and all capacities, to:</p>
<blockquote>
  <p style="text-indent: -15">1. execute for and on behalf of the undersigned,
  in the undersigned's capacity as a shareholder of SIGA Technology, Inc. (the
  &quot;Company&quot;), Forms 3, 4 and 5 in accordance with Section 16(a) of the
  Securities Exchange Act of 1934, as amended, and the rules thereunder;</p>
  <p style="text-indent: -15">2. do and perform any and all acts for and on
  behalf of the undersigned which may be necessary or desirable to complete and
  execute any such Form 3, 4 or 5 and timely file such form with the United
  States Securities and Exchange Commission and any stock exchange or similar
  authority; and</p>
  <p style="text-indent: -15">3. take any other action of any type whatsoever in
  connection with the foregoing which, in the opinion of such attorney-in-fact,
  may be of benefit to, in the best interest of, or legally required by, the
  undersigned, it being understood that the documents executed by such
  attorney-in-fact on behalf of the undersigned pursuant to this Power of
  Attorney shall be in such form and shall contain such terms and conditions as
  such attorney-in-fact may approve in such attorney-in-fact's discretion.</p>
</blockquote>
<p style="text-indent: 25">The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and perform any and every act
and thing whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney and
the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.</p>
<p style="text-indent: 25">This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms 3, 4 and 5 with
respect to the undersigned's holdings of and transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.</p>
<p style="text-indent: 25">IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 10th day of October, 2003.</p>
<dir>
  <dir>
    <p align="left" style="text-indent: 250">TransTech Pharma, Inc.</p>
    <p align="left" style="margin-left: 250">By: <u>&nbsp;&nbsp;&nbsp; /s/
    William V.Buccella&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </u><br>
    Name: William V. Buccella<br>
    Title: Senior Vice President-Legal Affairs<br>
    and Secretary</p>
  </dir>
</dir>

</body>

</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
